Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.
Giovanni GuaraldiJovana MilicEsteban MartinezAdeeba KamarulzamanCristina MussiniLaura WatersAnton PozniakPatrick MallonJürgen K RockstrohJeffrey Victor LazarusPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented global challenge that substantially risks reversing the progress in ending human immunodeficiency virus (HIV). At the same time, it may offer the opportunity for a new era of HIV management. This viewpoint presents the impact of COVID-19 on HIV care, including the Joint United Nations Programme on HIV/AIDS (UNAIDS) "three 90s" targets. It outlines how to enhance a patient-centered care approach, now known as the "fourth 90," by integrating face-to-face patient-physician and telemedicine encounters. It suggests a framework for prevention and treatment of multimorbidity and frailty, to achieve a good health-related quality of life, and to preserve intrinsic capacity in all people living with HIV.
Keyphrases
- coronavirus disease
- human immunodeficiency virus
- hiv aids
- antiretroviral therapy
- hiv infected
- hiv positive
- hepatitis c virus
- respiratory syndrome coronavirus
- healthcare
- primary care
- emergency department
- palliative care
- hiv testing
- sars cov
- study protocol
- combination therapy
- health insurance
- double blind
- affordable care act
- chronic pain